Biosante Pharmaceuticals shares owned by Northern Trust
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Northern Trust
from 13F filings
Historical chart of Northern Trust investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Northern Trust consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Biosante Pharmaceuticals by Northern Trust
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $11M | 188k | 59.66 |
2024-03-31 | $11M | 163k | 69.13 |
2023-09-30 | $9.9M | 170k | 58.06 |
2023-06-30 | $8.3M | 155k | 53.83 |
2023-03-31 | $5.6M | 140k | 39.72 |
2022-12-31 | $5.7M | 142k | 40.23 |
2022-09-30 | $4.4M | 137k | 32.11 |
2022-06-30 | $4.0M | 136k | 29.66 |
2022-03-31 | $3.5M | 125k | 28.11 |
2021-12-31 | $5.8M | 126k | 46.09 |
2021-09-30 | $3.9M | 118k | 32.82 |
2021-06-30 | $4.2M | 119k | 35.06 |
2021-03-31 | $4.2M | 117k | 35.76 |
2020-12-31 | $3.6M | 125k | 29.05 |
2020-09-30 | $3.5M | 124k | 28.17 |
2020-06-30 | $4.2M | 128k | 32.43 |
2020-03-31 | $5.4M | 131k | 40.72 |
2019-12-31 | $7.9M | 129k | 61.69 |
2019-09-30 | $9.7M | 133k | 72.91 |
2019-06-30 | $9.8M | 119k | 82.21 |
2019-03-31 | $8.2M | 117k | 70.53 |
2018-12-31 | $5.2M | 117k | 44.52 |
2018-09-30 | $6.7M | 118k | 56.51 |
2018-06-30 | $7.9M | 118k | 67.24 |
2018-03-31 | $6.5M | 112k | 58.18 |
2017-12-31 | $7.3M | 114k | 64.43 |
2017-09-30 | $6.0M | 114k | 52.49 |
2017-06-30 | $5.4M | 113k | 48.19 |
2017-03-31 | $5.2M | 107k | 48.19 |
2016-12-31 | $6.3M | 103k | 60.64 |
2016-09-30 | $6.8M | 101k | 66.82 |
2016-06-30 | $5.6M | 100k | 55.79 |
2016-03-31 | $3.3M | 99k | 33.70 |
2015-12-31 | $4.0M | 98k | 41.10 |
2015-09-30 | $3.4M | 91k | 37.74 |
2015-06-30 | $5.0M | 80k | 62.36 |
2015-03-31 | $4.7M | 75k | 62.53 |
2014-12-31 | $4.1M | 73k | 56.34 |
2014-09-30 | $2.1M | 75k | 28.24 |
2014-06-30 | $592k | 18k | 32.61 |
2014-03-31 | $353k | 11k | 32.61 |
2013-12-31 | $219k | 10k | 21.74 |